Stay updated on Lorlatinib Combos in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib Combos in Lung Cancer Clinical Trial page.

Latest updates to the Lorlatinib Combos in Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.3 was added to the record history, and entries for 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRecord History shows a new entry v3.3.2 and removal of v3.3.1, reflecting a metadata version update on the page. These are minor updates to the revision history that do not alter study information or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedA new revision entry v3.3.1 was added to the record history, and the previous v3.2.0 entry was removed.SummaryDifference0.1%

- Check40 days agoChange DetectedThe funding/data-timeliness notice was removed from the page. The rest of the study record page remains unchanged.SummaryDifference0.8%

- Check47 days agoChange DetectedA new version entry (2021-03-07) appears in the Record History, updating the recruitment status and related details.SummaryDifference0.1%

- Check83 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference13%

Stay in the know with updates to Lorlatinib Combos in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib Combos in Lung Cancer Clinical Trial page.